APM
PRAX icon

Avidity Partners Management’s Praxis Precision Medicines PRAX Stock Holding History

Avidity Partners Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-285,447
Closed -$3.46M – 105
2023
Q1 		$3.46M Buy
+285,447
New +$12M 0.12% 75

Other funds holding PRAX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

Avidity Partners Management's PRAX Position: Q2 2023 in Review

Avidity Partners Management sold out of Praxis Precision Medicines (PRAX) in Q2 2023, closing a stake of 285,447 shares — an estimated $3.46M sold.

Avidity Partners Management first reported a position in PRAX in Q1 2023 and held it in 1 quarter. The position peaked at $3.46M in Q1 2023. 78 funds tracked by Wall St. Rank hold PRAX as of Q2 2023.

  • Avidity Partners Management reported no remaining Praxis Precision Medicines position as of Q2 2023 after selling out during the quarter.
  • Avidity Partners Management sold 285,447 Praxis Precision Medicines shares in Q2 2023, an estimated $3.46M.
  • Avidity Partners Management first reported a position in Praxis Precision Medicines in Q1 2023 and held it in 1 quarter.
  • Avidity Partners Management's Praxis Precision Medicines position peaked at $3.46M in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2023.

Based on Avidity Partners Management's 13F filing for Q2 2023, filed 14 Aug 2023.